Emergent BioSolutions Inc ER4-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 02/26/21 CET
80.00quote price arrow down-1.00 (-1.23%)
52 week range
73.50 - 104.00

...

Loading . . .

KEY STATS

  • Open80.00
  • Day High80.00
  • Day Low80.00
  • Prev Close81.00
  • 52 Week High104.00
  • 52 Week High Date02/15/21
  • 52 Week Low73.50
  • 52 Week Low Date01/04/21
  • Market Cap5,097.6M
  • Shares Out53.1M
  • 10 Day Average Volume361.25
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change45.45

RATIOS/PROFITABILITY

  • EPS (TTM)4.61
  • P/E (TTM)17.35
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Emergent BioSolutions Inc News

There is no recent news for this security.

Latest ER4-FF News From Our Partners

QUOTE FINDER

Profile

MORE
Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as...
Fuad El-Hibri
Chairman
Robert Kramer Sr.
President
Richard Lindahl
Chief Financial Officer
Adam Havey
Executive Vice President
Atul Saran
Executive Vice President
Address
400 Professional Dr Ste 400
Gaithersburg, MD
20879-3457
United States